Printer Friendly

EMPYREAN DIAGNOSTICS INC. ANNOUNCES SUBSCRIPTIONS

 VANCOUVER, British Columbia, Dec. 7 /PRNewswire/ -- Empyrean Diagnostics Inc. President and Chief Executive Officer, Daniel Bland, is pleased to announce that subscriptions for 1,197,723 Units, having a total purchase price of $1,916,356.80, have been received by the company in relation to the non-brokered private placement previously announced on Sept. 27, 1993.
 Application for final approval of the Vancouver Stock Exchange has been made and the Units will be issued upon receipt of that final approval.
 Empyrean Diagnostics Inc., a wholly owned subsidiary of Empyrean Diagnostics Ltd. (Vancouver: EMD), has developed a proprietary, inexpensive, easy-to-use, whole blood rapid ELISA test-kit for the detection of HIV-1 and is currently licensing the manufacturing and marketing rights for the technology around the world.
 -0- 12/7/93
 /CONTACT: Fraser B. Martin, director, 800-567-8181 or 604-687-6223/
 (EMD.)


CO: Empyrean Diagnostics Inc. ST: British Columbia IN: MTC SU:

MF-EH -- LA016 -- 1286 12/07/93 12:41 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 7, 1993
Words:156
Previous Article:WESTERN ANNOUNCES NEW GAS PURCHASE AND SALES AGREEMENT
Next Article:BRIO INDUSTRIES INC. ('BRIOF-Q') -- Options Granted
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters